Aerin Medical Inc. announced it raised $34.9 Million in an initial filing from an offering of $60 Million

Company

Location

About

Aerin’s mission is to provide Ear, Nose, and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal airway conditions. The company’s FDA-cleared products, VivAer® for nasal airway obstruction and RhinAer® for chronic rhinitis, leverage Aerin’s proprietary, temperature-controlled technology, which allows ENT physicians to reliably improve patients’ symptoms with an in-office procedure performed with local anesthetic. For more information, please visit www.aerinmedical.com.